Statistics suggested that Christy’s odds of survival were grim, so she leaned into her faith and kept a positive outlook. She tried to control what she could. And, critically, she received biomarker testing.
Explore the urgent need for the Colorectal Cancer Early Detection Act (HR 7714), legislation aimed at combating the rising incidence of colorectal cancer among younger adults through enhanced screening, education, and research.
People with RAS-mutated metastatic colorectal cancer (mCRC) have seen little progress in first-line treatment options over the past two decades, but that could soon change for thousands of new patients, according to a press release from Cardiff Oncology.
To those fortunate enough to work with him, Dr. Weber embodied a powerful and inspiring combination of a brilliant mind, tireless work ethic, singular sense of humor, and deeply caring nature.
Lutris Pharma, a biopharmaceutical company established to improve cancer therapy and patient quality of life, is enrolling patients in a clinical trial to study the effectiveness of a gel (LUT014) to treat acneiform lesions in stage IV (metastatic) colorectal cancer patients.
The 340B program, designed to aid low-income patients, is exploited by hospitals for profit. The Colorectal Cancer Alliance demands Congress reform it to ensure discounts benefit those in need.
The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Peter P. Lee, MD, of City of Hope will receive $1 million over two years.
The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Kevin Van Der Jeught, Ph.D., of the University of Miami, will receive $200,000 over two years.
The Colorectal Cancer Alliance’s philanthropic research fund, Project Cure CRC, has announced another awardee. Yekaterina Zaytseva, PhD, of the University of Kentucky will receive $200,000 over two years.
The Alliance’s 45+ Reasons campaign is part of the Cycles of Impact initiative launched and supported by Independence Blue Cross in 2022 to address the urgent public health issue of colorectal cancer among the Black population.
This bipartisan legislation aims to improve participation in clinical trials by addressing major barriers such as non-medical expenses, trial location accessibility, diverse participation, and financial implications for patients.
The treatment option is for patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer (CRC) who have received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
The U.S. Court of Appeals for the Fifth Circuit reversed a district court decision that had ruled provisions in the Affordable Care Act (ACA), which provide for no-cost preventive screening for colorectal cancer and other conditions, unconstitutional.
Several different types of colonoscopy prep regimens are available today, including prescription and over-the-counter options. While it is important to consult your healthcare provider for guidance, it can be helpful to conduct some of your own research.
Alliance Board of Directors member Avi Benaim delighted 2023's Porsche car raffle winner with a call from the Blue Hope Bash stage, captured live in front of guests.